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Abstract
Phosphorylation of insulin receptor substrate (IRS)-2 on tyrosine residues is a key event in IGF-1/insulin signaling and leads
to activation of the PI 3-kinase and the Ras/MAPK pathway. Furthermore, phosphorylated serine/threonine residues on IRS-2
can induce 14-3-3 binding. In this study we searched IRS-2 for novel phosphorylation sites and investigated the interaction
between IRS-2 and 14-3-3. Mass spectrometry identified a total of 24 serine/threonine residues on IRS-2 with 12 sites unique
for IRS-2 while the other residues are conserved in IRS-1 and IRS-2. IGF-1 stimulation led to increased binding of 14-3-3 to
IRS-2 in transfected HEK293 cells and this binding was prevented by inhibition of the PI 3-kinase pathway and an Akt/PKB
inhibitor. Insulin-stimulated interaction between endogenous IRS-2 and 14-3-3 was observed in rat hepatoma cells and in
mice liver after an acute insulin stimulus and refeeding. Using different IRS-2 fragments enabled localization of the IGF-1-
dependent 14-3-3 binding region spanning amino acids 300–600. The 24 identified residues on IRS-2 included several 14-3-3
binding candidates in the region 300–600. Single alanine mutants of these candidates led to the identification of serine 573
as 14-3-3 binding site. A phospho-site specific antibody was generated to further characterize serine 573. IGF-1-dependent
phosphorylation of serine 573 was reduced by inhibition of PI 3-kinase and Akt/PKB. A negative role of this phosphorylation
site was implicated by the alanine mutant of serine 573 which led to enhanced phosphorylation of Akt/PKB in an IGF-1 time
course experiment. To conclude, our data suggest a physiologically relevant role for IGF-1/insulin-dependent 14-3-3 binding
to IRS-2 involving serine 573.
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Introduction
Insulin and insulin-like growth factor (IGF)-1 mediate their
metabolic and mitogenic effects on target tissues through
activation of the IGF-1/insulin receptor. The activated receptors
function as tyrosine kinases that phosphorylate proteins including
the insulin receptor substrate proteins (IRS)-1 and -2 [1,2]. This
leads to activation of the PI 3-kinase-Akt/PKB pathway and
promotes glucose and lipid storage, protein synthesis and cell
survival. The mitogenic effects are mediated by the activation of
the Ras/MAPK pathway, leading to differentiation and prolifer-
ation. The signal diversification is modulated by the IRS proteins
and their phosphorylation status. After being phosphorylated on
tyrosine residues the IRS proteins serve as docking molecules for
src homology 2 (SH2) domain containing intracellular signaling
proteins, e.g. p85 regulatory subunit of PI 3-kinase [3,4]. IRS-1
and IRS-2 proteins also are substrates for a variety of serine/
threonine kinases [5–12]. Given the essential and complementary
functions of IRS-1 and IRS-2 in transducing and terminating the
IGF-1/insulin signal it is evident that dysregulation of serine/
threonine phosphorylation can have important consequences for
cellular metabolism and cell survival. Alignment of IRS-1 and -2
protein sequences shows a high sequence identity and conservation
of some but not all serine and threonine residues. The site-specific
regulation and function of the phosphorylated serine/threonine
residues in IRS proteins make it necessary to identify and
characterize the individual phospho-sites in the individual
proteins. Notably, hyperphosphorylation of serine/threonine
residues in IRS-1 is a key event in the development of insulin
resistance [1,13,14], while the phosphorylation of certain residues
can enhance insulin signaling [8,15,16]. Less is known about
individual phospho-sites in IRS-2 and the (patho)physiological
consequences of serine/threonine phosphorylation of IRS-2 [17].
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14-3-3 proteins are highly conserved and expressed in a wide
range of eukaryotes. The high level of functional conservation of
the 14-3-3 proteins is indicated by the finding that the isoforms
from yeast, plant and mammals are functionally interchangeable
[18]. In humans seven genes have been identified to encode for
seven 14-3-3 isoforms. They form homo- or heterodimers with the
exception of 14-3-3s, which preferentially forms homodimers
[19]. Studies with dimerization-deficient 14-3-3 mutants revealed
a significant role for dimerization, that seems to be necessary for
phosphorylation-dependent interaction with target proteins [18].
Crystal structures show that each 14-3-3 protein resembles a
curved structure with a central groove and within this central
groove the residues are strictly conserved [20]. The central groove
enables 14-3-3 proteins to bind to a phosphorylated serine or
threonine residue within specific motifs in target proteins, termed
mode I (RSXpS/pTXP, X denotes any amino acid) and mode II
(RX(F/Y)XpS/pTXP) [21,22]. The phosphorylation of serine and
threonine sites in 14-3-3 binding partners is an important
prerequisite for the interaction although the aforementioned
motifs are not completely mandatory and in rare cases phosphor-
ylation is not required [23–25]. There are studies reporting that
interaction between 14-3-3 and the target protein is based upon
phosphorylation of a single serine/threonine residue [26–28], but
there are also studies that found two simultaneously phosphory-
lated serine/threonine residues to mediate interaction with 14-3-3
proteins [29–31]. 14-3-3 proteins can act in several ways:
conformational change of the target protein [32], blocking of
sequence specific or structural features [33], scaffolding of protein
clusters to connect signaling pathways [34] and intracellular
trafficking [35]. Of note, the possibility that more than one mode
of action is used simultaneously is likely.
The abundance of 14-3-3 proteins and their broad range of
interaction partners explain why they are key regulators of various
intracellular processes, such as neuronal development, cell cycle
control, cell growth control, apoptosis and control of gene
transcription. Recently, IRS-2 was identified by a differential 14-
3-3 affinity capture approach as novel 14-3-3 binding protein
regulated by IGF-1/insulin signaling [36]. Interaction between
IRS-1 and 14-3-3 has been described before, but since IRS-1 and -
2 have similar and distinct properties the characterization of
interaction between 14-3-3 and IRS-2 has to be investigated. It is
likely that the binding of 14-3-3 to IRS-2 plays an important role
in IGF-1/insulin signal transduction and that IGF-1/insulin-
induced phosphorylation of certain serine/threonine residues in
IRS-2 enables the 14-3-3 interaction. The aim of the present study
was to identify IGF-1/insulin-dependent serine/threonine phos-
phorylation sites of IRS-2 with a special focus to elucidate and
characterize the 14-3-3 binding sites on IRS-2.
Results
Identification of Phosphorylated Serine/threonine
Residues on IRS-2 by Mass Spectrometry
To identify the serine/threonine residues of IRS-2 that are
involved in the IGF-1/insulin signaling cascade GFP-IRS2
encoding mouse IRS-2 was expressed transiently in HEK293 cells
and cells were either left unstimulated or stimulated with IGF-1 for
30 min. Following purification, SDS-PAGE and tryptic digestion
of IRS-2 protein bands liquid chromatography mass spectrometry
(LC-MS) was applied to identify phosphorylated peptides. Mass
spectrometric fragmentation pattern were used to localize the
phosphorylation sites. The sequence coverage was 92% and a total
of 24 phosphorylated serine/threonine residues were identified.
According to IRS-2 mouse numbering phosphorylations were
detected at the residues Ser-66, Ser-303, Ser-305, Ser-347, Ser-
385, Ser-388, Thr-401, Thr-517, Ser-556, Ser-573, Ser-675, Ser-
722, Ser-727, Ser-728, Ser-762, Ser-907, Ser-968, Ser-977, Ser-
999, Ser-1089, Ser-1151, Ser-1165, Ser-1190 and Ser-1266 (see
Table S1 and S2 for the identified phosphopeptides). In Figure 1
the sections of the IRS-2 mouse sequence are shown that contain
the 24 phosphorylated residues (labeled in bold red). Correspond-
ing residues found in human IRS-2 and mouse/human IRS-1 are
also shown. Of note, Ser-305 and Ser-1266 were the only sites that
were unique to the IGF-1 treated sample. However, our mass
spectrometric approach was suitable to identify phosphorylation
sites, but did not allow evaluation of changes in the phosphory-
lation levels due to IGF-1 treatment. Interestingly, some residues
are unique for IRS-2 (Ser-66, Thr-401, Ser-556, Ser-727, Ser-728,
Ser-968, Ser-977, Ser-999, Ser-1089, Ser-1151, Ser-1190 and Ser-
1266), whereas some are conserved in IRS-1 and -2 (Ser-303, Ser-
305, Thr-347, Ser-385, Ser-388, Thr-517, Ser-573, Ser-675, Ser-
722, Ser-762, Ser-907 and Ser-1165).
Co-immunoprecipitation and Overlay Assay Indicate
Interaction of 14-3-3 and IRS-2 upon IGF-1 and Insulin
Stimulation
IGF-1 stimulation leads to interaction of IRS-2 and 14-3-3 as
has been shown by Ogihara et al. and Dubois et al. [36,37]. It is
known that the majority of interactions between 14-3-3 proteins
and their partners are dependent on phosphorylation of serine/
threonine residues within discrete motifs. In a first experiment the
interaction between IRS-2 and 14-3-3 was verified in HEK293 -
cells transiently expressing GFP-IRS2. Immunoprecipitation of
endogenous 14-3-3 also pulled down IRS-2 as indicated by
western blot (Figure 2A). IGF-1 stimulation increased the amount
of IRS-2 that was pulled down, whereas incubation with the
covalent PI 3-kinase inhibitor wortmannin decreased binding
between 14-3-3 and IRS-2. Direct protein-protein interaction was
visualized by overlay assay and showed that upon stimulation with
IGF-1 for 30 min the 14-3-3 binding to IRS-2 was significantly
increased, whereas it was significantly decreased by treating cells
30 min prior IGF-1 stimulation with another PI 3-kinase inhibitor,
namely PI-103, which targets the catalytic subunit p110 of PI 3-
kinase (Fig. 2B, C). These data suggested that the activation of the
PI 3-kinase pathway induced phosphorylation on the IRS-2
molecule on serine or threonine residues within a 14-3-3 binding
motif. To evaluate the physiological importance of 14-3-3 binding
to IRS-2 we tested if the overlay assay could show 14-3-3 binding
to IRS-2 in mouse liver after an acute insulin stimulus. Mice were
fasted overnight, injected intravenously with insulin and after
10 min liver was taken and IRS-2 was immunoprecipitated. The
overlay assay in Figure 2D and the densitometric analysis thereof
(Fig. 2E) showed a significant increase in the ability of 14-3-3 to
bind to IRS-2. Another set of mice was fasted overnight and either
refed for 4 hours or injected intraperitoneally with insulin for
30 min before liver was taken and IRS-2 was immunoprecipitated.
Again, 14-3-3 showed increased binding to IRS-2 after the acute
insulin stimulus in the overlay assay, but also the refeeding
condition led to an increased binding of 14-3-3 to IRS-2 when the
overlay signal was normalized against total protein content
(Fig. 2F, G). Of note, the differing molecular weight of the IRS-
2 protein in the refed state indicates that 30 min of insulin
stimulation did not lead to such extensive posttranslational
modifications on the IRS-2 protein as the physiological stimulus
of refeeding over 4 hours did. In conclusion, refeeding led to
increased interaction between IRS-2 and 14-3-3, thus implicating
a physiological importance of this interaction.
Ser-573 as 14-3-3 Binding Site
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Localization of the 14-3-3 Binding Region on IRS-2
Next, we aimed to localize the binding site that mediated 14-
3-3 binding to IRS-2. By comparing the 14-3-3 binding motifs
RSXpS/pTXP and RX(F/Y)XpS/pTXP with the sequences
surrounding the identified phosphorylated residues it became
apparent that potential 14-3-3 binding motifs frequently
appeared in an amino acid area between the PTB (phosphotyr-
osine binding) and the KRLB (kinase regulatory loop binding)
domain on IRS-2 stretching from amino acid position 300–600.
In Table 1 the 5 residues with surrounding amino acid
sequence that corresponded to a 14-3-3 binding motif are
shown. To prove that region 300–600 was important for 14-3-3
binding and to exclude possible other regions IRS-2 fragments
spanning different sections of the protein were generated. In
Figure 3A a schematic illustration of the generated fragments is
displayed. Two fragments from position 1–300 and 1–600
encompassed the N-terminal part of the IRS-2 molecule
including the PH (pleckstrin homology) and the PTB domain.
The C-terminal part was also divided into two fragments
spanning amino acids 301–1321 and 601–1321, both containing
the KRLB domain. The 5th construct comprised amino acids
301–600. Constructs were GFP tagged at the N-terminus and
expressed transiently in HEK293 cells to check for residual
binding of 14-3-3 by overlay assay. While equal amounts of
DNA were used to transfect the constructs, the protein
expression levels differed between IRS-2 wild type and
truncated IRS-2 forms (Fig. 3B). The overlay assay showed
regulated binding of 14-3-3 to wild type IRS-2, but no
interaction between 14-3-3 and the constructs GFP-IRS2-1-
300 and GFP-IRS2-601-1321 (Fig. 3C). A strong and almost
unregulated interaction was observed with the construct GFP-
IRS2-1-600. On the contrary, the construct GFP-IRS2-301-
1321 showed regulated 14-3-3 binding upon IGF-1 stimulation
and reduced binding by PI-103 treatment. These data showed
the importance of the region 301–600 for 14-3-3 binding. To
test if this region alone was capable of binding to 14-3-3 the
fragment 301–600 was tested (Fig. 3C). This fragment also
showed almost unregulated binding to 14-3-3 similar to GFP-
IRS2-1-600.
Identification of Serine 573 as IGF-1-dependent 14-3-3
Interaction Site on IRS-2
Having localized the 14-3-3 binding region to amino acids
301–600 we focused on the phosphorylated serine/threonine
residues that were identified by mass spectrometry and
corresponded to a 14-3-3 binding motif as shown in Table 1.
After single mutation of each serine/threonine to alanine
residual 14-3-3 binding upon IGF-1 stimulation was tested in
transiently transfected HEK293 cells by overlay assay (Fig. 4A).
The mutation of serine 573 to alanine blocked the basal and
IGF-1-dependent 14-3-3 interaction completely, while the other
mutants showed similar interaction with 14-3-3 when compared
with IRS-2 wild type (Fig. 4A, B). Flp-In HEK293 cells were
used for stable transfection with GFP-IRS2 or GFP-IRS2-
S573A and showed similar results (Fig. 4C, D). Notably, no
difference in the ability of the two PI 3-kinase inhibitors used
(PI-103 in Fig. 4A, wortmannin in Fig. 4B, C) to decrease IGF-
1-mediated 14-3-3 binding to IRS-2 was detected.
Sequence Alignments of Different IRS-2 Species and
Generation of a Phosphospecific Antibody Against Ser-
573
Aligning of IRS-2 protein sequences from mammalian and
amphibian species showed that serine 573 and the flanking
motif is highly conserved (Fig. 5A). Sequence alignment of
mouse/rat IRS-1 and IRS-2 showed serine 522 of IRS-1 is
homologue to serine 573 of IRS-2 (Fig. 5B). To proceed with
the characterization of the 14-3-3 binding site serine 573 a
phospho-site specific antibody was generated. To test the
specificity of the antibody Flp-In HEK293 cells stably expressing
GFP-IRS2 or GFP-IRS2-S573A were incubated with IGF-1 or
wortmannin for 30 min. While the antibody did not detect any
phosphorylation signal in the 573 alanine mutant, it detected
IGF-1 stimulated phosphorylation of serine 573 in wild type
IRS-2. Again, wortmannin blocked the IGF-1-mediated phos-
phorylation of serine 573 (Fig. 5C). The antibody recognized
different bands, which all corresponded to the IRS-2 protein
according to the reblot. This recognition of different sub-species
of the IRS-2 protein by immunoblotting is well in line with
recent data [5]. To test whether the antibody recognized the
homologue residue in human IRS-2 (serine 577) or in IRS-1
(serine 522 in rat and mouse numbering), HEK293 cells were
co-transfected transiently with plasmids containing the insulin
receptor and either mouse IRS-2, human IRS-2 or rat IRS-1
(Fig. 5D). The antibody detected phosphorylation of mouse
IRS-2 Ser-573 and human IRS-2 Ser-577, but not IRS-1 Ser-
522.
Akt/PKB Activity is Important for Phosphorylation of
Serine 573 and the Interaction of 14-3-3 with IRS-2
The sequence surrounding serine 573 (RKRTYpS573) con-
formed to a potential consensus site for phosphorylation by
Akt/PKB (RXRXXpS/T, X denotes any amino acid). To test
whether Akt/PKB was involved in phosphorylation of serine
573, Flp-In HEK293 cells stably expressing GFP-IRS2 were
incubated with an Akt/PKB inhibitor (Akti-1/2) before IGF-1
stimulation. The compound Akti-1/2 reduced the phosphoryla-
tion of Thr-308 of Akt/PKB and subsequently the IGF-1-
stimulated phosphorylation of serine 573 (Fig. 6A, B). Of note,
the Flp-In HEK293 cells showed phosphorylation of Thr-308-
Akt/PKB in the serum starved condition, which may influence
phosphorylation of serine 573. To further test whether Akt/
PKB inhibition also influences 14-3-3 binding to IRS-2, we
performed a GFP pulldown and subsequent overlay assay to
visualize 14-3-3 binding to IRS-2. IGF-1 stimulation resulted in
increased binding of 14-3-3 to IRS-2, which was prevented by
incubation with Akti-1/2 before IGF-1 stimulation (Fig. 6C).
These findings led us to the conclusion that Akt/PKB activity
was necessary for serine 573 phosphorylation and the IGF-1-
stimulated 14-3-3 binding to IRS-2.
Monitoring 14-3-3 Interaction with IRS-2 and Serine 573
Phosphorylation in Rat Hepatoma Cells
The preceding experiments were performed in transiently or
stably transfected HEK293 cells. To test whether endogenously
expressed IRS-2 was phosphorylated at serine 573 and whether
Figure 1. Sequence alignments of IRS-1 and -2 species. Protein sequences from mouse IRS-2 (NP_001074681.1), human IRS-2 (NP_003740.2),
mouse IRS-1 (NP_034700.2) and human IRS-1 (NP_005535.1) were aligned. The sequences were searched for homologue residues of mouse IRS-2 that
were identified by mass spectrometry and marked in bold red. Shown are only parts of the sequences that contain an identified phosphorylated
serine/threonine residue. The term ‘‘numbering’’ indicates the amino acid position of the first amino acid in every line.
doi:10.1371/journal.pone.0043296.g001
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Figure 2. Co-immunoprecipitation and overlay assays indicate interaction of 14-3-3 and IRS-2 upon IGF-1/insulin stimulation. A.
HEK293 cells were transiently transfected with GFP or GFP-IRS2 and after serum starvation cells were incubated with 50 ng/ml IGF-1 for 30 min or
after preincubation with 100 nM wortmannin for 30 min. 400 mg total protein was used for immunoprecipitation with 14-3-3 antibody (C-17) and
samples were separated on 5–15% gradient gel. Upper membrane was incubated with IRS-2 antibody, lower membrane with 14-3-3 antibody (K-19).
B. HEK293 cells were transfected with GFP-IRS2 and stimulation was carried out after starvation for serum overnight with 50 ng/ml IGF-1 for 30 min
or subsequently after preincubation with 1 mM PI-103 for 30 min. 250 mg of total protein was pulled down using GFP-TrapH. SDS-PAGE followed
transfer onto nitrocellulose membranes. Overlay assay followed stripping of the membrane and reprobing with GFP antibody as loading control. C.
Extent of interaction was quantified by scanning densitometry of blots and normalization for GFP-IRS2 serum starved condition (mean 6 SEM; n= 4;
*p,0.05 serum starved vs. IGF-1 or IGF-1 vs. PI-103/IGF-1). D. Male C57Bl/6 mice were fasted overnight and injected intravenously with 2 IU
(international units) insulin. After 10 min liver was taken and 500 mg of total protein was immunoprecipitated with IRS-2 antibody. After performing
Ser-573 as 14-3-3 Binding Site
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14-3-3 bound to IRS-2 upon IGF-1 or insulin stimulation, Fao (rat
hepatoma) cells were treated with IGF-1 or insulin for 30 min.
Insulin stimulation led to a strong interaction of 14-3-3 with IRS-2
and increased Akt/PKB phosphorylation at Thr-308 (Fig. 7A).
Stimulation with IGF-1 did not result in activation of the PI 3-
kinase-Akt/PKB pathway similar to previous data [5], probably
due to low IGF-1 receptor expression levels and did not lead to
increased 14-3-3 binding above basal levels. Therefore, insulin
stimulation was used to monitor phosphorylation of serine 573 in a
time course experiment in Fao cells. Fao cells were starved for
serum and incubated with insulin for the indicated time points.
Serine 573 showed a slight basal phosphorylation, which modestly
increased after 5 and 30 min and peaked at 60, 90 and 120 min of
insulin stimulation before decreasing (Fig. 7B) again.
Positive Influence of S573A Mutant on Akt/PKB
Phosphorylation
To investigate if the phosphorylation of serine 573 had an
influence on downstream signaling of the IGF-1/insulin signaling
cascade, the phosphorylation of Thr-308 and Ser-473 of Akt/PKB
in HEK293 cells transfected transiently with GFP-IRS2 or GFP-
IRS2-S573A was assessed after incubation with IGF-1 for 5, 15, 30,
60, 120 and 240 min. IRS-2 wild type expressing cells showed
induction of phosphorylation of Thr-308 and Ser-473 after 5 min of
IGF-1 stimulation and this stimulation was decreased after 120 min
(Fig. 8). In contrast, this downregulation was impaired in the S573A
mutant expressing cells. This data suggested that phosphorylation of
serine 573 negatively regulated IGF-1 signaling.
Involvement of Other IGF-1/insulin-dependent 14-3-3
Binding Sites on IRS-2
The results of the overlay assay using alanine mutants of the
phosphorylation sites between amino acids 301–600, identified in
the mass spectrometric approach, did not indicate a second site
relevant for the 14-3-3 binding to IRS-2 (Fig. 4). However, with a
differential 14-3-3 affinity approach using insulin-stimulated HeLa
cells and the yeast 14-3-3 isoforms BMH1 and BMH2 as capture
proteins, Dubois et al. identified IRS-2 as a 14-3-3 interaction
protein and by mass spectrometry also identified an IRS-2 derived
peptide containing a phosphorylated serine corresponding to
serine 556 [36]. To study the potential involvement of this site
together with serine 573 in 14-3-3 binding we applied a GST
pulldown assay, where cell lysates were mixed with GST tagged
14-3-3b or 14-3-3e. Western blot membranes were incubated with
GST antibody to ensure equal pulldown and with GFP to visualize
the amount of protein that interacted with GST-14-3-3. First, we
applied the GST pulldown for the single serine 573 to alanine
mutant of IRS-2 to confirm serine 573 as 14-3-3 binding site.
Unexpectedly, the GST pulldown experiments showed no reduced
interaction of IRS2-S573A with 14-3-3 (Fig. 9A) in contrast to the
results of the overlay assays in Figure 4. The interaction was also
not reduced using the single S556A mutant (data not shown) and
also a double GFP-IRS2 mutant S556A/S573A failed to disrupt
14-3-3 binding (Fig. 9B). Together, these results may either reflect
restrictions of the GST pulldown in the context with our protein
constructs of IRS-2 and 14-3-3 or give a hint for an additional
binding site of 14-3-3 in IRS-2 that does not influence the binding
detectable in the overlay assay but the binding visualized in the
GST pulldown.
Discussion
IRS-1 and -2 as intracellular signaling nodes contain numerous
serine and threonine residues that can be modified by protein
kinases and protein phosphatases. For IRS-1 this has been shown
extensively [8,11,38–40]. Additionally, the interaction of IRS-1
and 14-3-3 has been investigated in some studies. 14-3-3 binding
to IRS-1 was found to be influenced by insulin in HepG2 cells [37]
but not in 3T3-L1 adipocytes [41]. Xiang et al. proposed a role for
14-3-3 in IRS-1 trafficking in COS-7 cells [42], whereas Oriente
et al. and Kosaki et al. observed an influence of 14-3-3 on IRS-1
associated kinases and their activity in NIH-3T3 fibroblasts and
3T3-L1 adipocytes [41,43].
Less is known about individual serine/threonine phosphorylation
sites on IRS-2, the interaction of 14-3-3with IRS-2 and the influence
on cellular metabolism. The IRS-2 interaction with 14-3-3 proteins
hasbeendocumented in large-scaleproteomicstudies,butonlyasone
of many interaction partners without any further characterization
[44–46]. Ogihara et al. showed interaction of overexpressed IRS-2
and14-3-3 inSf9 cells [37]andDubois et al. showed IRS-2as14-3-3
interaction partner upon IGF-1 stimulation involving the PI 3-kinase
pathway in HEK293 cells [36].
This interaction was verified here in different cell culture models
and in the liver of mice in vivo. In addition, we present here a
pattern of 24 phospho-sites of IRS-2 after IGF-1 stimulation and
the IGF-1/insulin-regulated 14-3-3 binding region on IRS-2
involving the novel IRS-2 serine phosphorylation site 573. We
showed that upon insulin or IGF-1 stimulation 14-3-3 associated
with IRS-2 in transiently transfected HEK293 cells, in Flp-In
HEK293 cells that stably expressed IRS-2 and in Fao cells, which
expressed IRS-2 endogenously. In addition, we could provide
evidence that the IGF-1/insulin-dependent activation of the PI 3-
kinase-Akt/PKB pathway was necessary for the IGF-1/insulin-
stimulated phosphorylation of serine 573 and the 14-3-3 binding
of IRS-2. Our data suggest that serine 573 potentially is involved
in the negative regulation of IGF-1/insulin signaling, since the 573
alanine mutant led to increased Akt/PKB signaling. In mice liver
14-3-3 associated with IRS-2 upon insulin stimulation and
refeeding, thus indicating the physiological occurrence of this
interaction.
We used the IRS-2 mouse sequence to identify novel
phosphorylation sites on IRS-2 and the mass spectrometry
approach revealed 24 phosphorylated serine/threonine residues.
These sites seem to be conserved in human IRS-2 since all sites
could also be found in the human IRS-2 protein sequence. In
addition, certain sites could be found in the corresponding human
and mouse protein sequences of IRS-1. Phosphorylation of serine
675 and serine 907 after insulin stimulation has already been
investigated and described by our group [5]. Serine 303 has a
homologue in the human IRS-2 protein sequence - serine 270.
This site has been described as substrate for S6K1 and as part of
TNF-a-induced insulin resistance [47]. Little is known about the
other sites that were identified by our screen. Truncated versions
of the IRS-2 protein, spanning 5 different segments, revealed the
area residing between amino acid position 301 and 600 to be
overlay assay membrane was stripped and reprobed with IRS-2 antibody as loading control. Two mice of each group are shown. E. Densitometric
analyses of 14-3-3 interaction with IRS-2. Overlay signal was normalized for total IRS-2 protein content (mean6 SEM; n = 4; *p,0.05 fasted vs. insulin).
F. Male C57Bl/6 mice were fasted overnight, refed for 4 hours or injected intraperitoneally with insulin for 30 min. Procedure as in G. Four mice of
each group are shown. G. 14-3-3 interaction with IRS-2 was quantified by scanning densitometry of immunoblots and normalization for IRS-2 protein
(mean 6 SEM; n = 4; *p,0.05 fasted vs. refed and insulin stimulation).
doi:10.1371/journal.pone.0043296.g002
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important for 14-3-3 binding. Within this region our mass
spectrometric approach identified several phosphorylated residues,
but only mutation of serine 573 to alanine abrogated the 14-3-3
interaction with IRS-2 in the overlay assay. Ser-573 and the
surrounding amino acids (RKRTYS573SLTT) do not completely
conform to a 14-3-3 binding motif with the lack of proline at
position +2 relative to the phosphorylated serine being the most
prominent feature to be different. However, a proline in positin +2
Figure 3. The area spanning amino acids 301–600 on IRS-2 is the 14-3-3 binding region. A. Schematic illustration of truncated IRS-2
constructs to identify the 14-3-3 binding region. B. 20 mg of protein was separated on a 5–15% gradient gel and membrane was probed with GFP
antibody to check expression and molecular weight of truncated IRS-2 versions. The arrow indicates a longer exposure time. C. HEK293 cells were
transfected with either GFP-IRS2 or truncated versions of IRS-2 (GFP-IRS2-1-300, GFP-IRS2-1-600, GFP-IRS2-301-1321, GFP-IRS2-601-1321, GFP-IRS2-
301-600), starved for serum overnight and stimulated for 30 min with 50 ng/ml IGF-1 or subsequently after preincubation with 1 mM PI-103 for
30 min. With GFP-TrapH 250 mg protein was pulled down and samples were subjected to overlay assay. For loading and expression control
membranes were stripped and reprobed for GFP.
doi:10.1371/journal.pone.0043296.g003
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is found in only 50% of the target sites as has been reported by
Johnson et al [48]. In addition, if the target sequence would match
the consensus motif completely, the strength of binding would not
give appropriate regulation of this protein [49]. The phosphory-
lation of serine 573 was increased upon IGF-1/insulin stimulation
in a PI 3-kinase-Akt/PKB-dependent manner, thus under the
same conditions when the 14-3-3/IRS-2 interaction took place.
Notably, pharmacological inhibition of PI 3-kinase using wort-
mannin or PI-103 or inhibition of Akt/PKB using Akti-1/2
prevented the enhanced phosphorylation of serine 573 and the
increased 14-3-3 binding of IRS-2.
We focused on the characterization of serine 573 since a
physiological importance of serine 573 is suggested by the fact that
sequence alignments of different mammalian species showed
complete sequence accordance, and even an amphibian sequence
showed partial accordance. We could observe phosphorylation of
serine 573 of mouse IRS-2 with insulin and IGF-1 and also
phosphorylation of the corresponding residue serine 577 in human
IRS-2. A time course of serine 573 phosphorylation in Fao cells
showed peak phosphorylation levels after 60, 90 and 120 min of
insulin treatment. Moreover, mutation of this site to alanine
displayed clear effects on IGF-1/insulin signal transduction.
IRS-1 and IRS-2 display a similar architecture and partially
overlapping functions, therefore the IRS-1 sequence was screened
for a homologue position corresponding to serine 573 of IRS-2.
Giraud et al. described the homologue serine 522 in IRS-1 [50].
They showed insulin-dependent phosphorylation of serine 522 in
L6 myoblasts and myotubes and identified Akt/PKB or a kinase
downstream of Akt/PKB as kinase for its phosphorylation and
provided evidence for a negative role of serine 522 phosphoryla-
tion. Serine 573 on IRS-2 also resides in an Akt/PKB consensus
motif (RXRXXpS/T). Treating cells with an Akt/PKB inhibitor
resulted in significantly reduced phosphorylation of serine 573 and
further experiments showed increased Akt/PKB phosphorylation
upon IGF-1 stimulation in the S573A mutant compared to IRS-2
wild type. In conclusion, our data suggested comparable
regulation and function of the homologue serine 573 and 522 in
IRS-2 and IRS-1, but the implication of serine 522 in 14-3-3
binding of IRS-1 has not been reported yet.
The data of the overlay assay indicated that only one
phosphorylated residue on IRS-2 was sufficient to trigger IGF-
1/insulin-dependent 14-3-3 interaction with IRS-2. This would be
in line with several other studies which also identified single
phosphorylated residues as 14-3-3 interaction site [26–28].
However, there are also other reports that showed 14-3-3 binding
to two simultaneously phosphorylated serine/threonine residues
on the same target protein (see [48] for a collection of reported
binding partners). Serine 556 appeared in the study from Dubois
et al. to be phosphorylated after insulin stimulation in HeLa cells
and we identified the same residue in our mass spectrometric
approach. This opened the possibility that perhaps serine 556 and
serine 573 were 14-3-3 binding sites. The S556A mutant showed
regulated binding of 14-3-3 in the overlay assay, hence arguing
against S556A as a 14-3-3 binding site. To support these findings
with another methodical approach GST pulldown experiments
were conducted. Unexpectedly, both single mutants S556A and
S573A did interact with GST-14-3-3 and also the double mutant
S556A/S573A failed to disrupt the interaction. The cause of this
discrepancy between the overlay assay and GST pulldown cannot
be explained yet, but we speculate that the S573A mutant
probably failed to disrupt interaction of 14-3-3 with IRS-2 in the
GST pulldown due to the presence of other proteins stabilizing 14-
3-3 binding or preventing regulated binding of exogenously added
GST-14-3-3 protein. Of course a second IGF-1/insulin-dependent
14-3-3 binding site on IRS-2 cannot be excluded.
How can the persuasive result of the overlay assay be explained?
A possibility is partial renaturation of the IRS-2 protein on the
nitrocellulose membrane. The renaturation process probably was
effective enough to enable binding of 14-3-3 to the phospho-serine
573 motif, whereas the second binding site might not have been
easily accessible and full renaturation of the IRS-2 protein would
have been required. This may have led to abrogation of 14-3-3
binding in the S573A mutant in the overlay assay, despite the
presence of a second binding site.
The 14-3-3 protein family shows high overall sequence
conservation, in the central binding groove the residues are
strictly conserved [20] and the phosphopeptide bonds are build
with 3 absolutely conserved residues [51]. In addition, the high
level of conservation is emphasized by the fact that 14-3-3 isoforms
from yeast, plant and mammals are functionally interchangeable
[18]. The aforementioned properties show that the two 14-3-3
isoforms b and e used in this study for the GST pulldowns and 14-
3-3f for the overlay assays were adequate to investigate 14-3-3
binding sites on IRS-2.
How could the interaction of IRS-2with 14-3-3 proteins influence
downstream insulin signaling? The rigid structure of the 14-3-3
proteins led to thehypothesis that 14-3-3proteinsprovide themselves
as an anvil whereon the target protein can be restructured/reshaped
[18]. Experimental data from Datta et al. showed that upon 14-3-3
binding to serine 316 of BAD (Bcl-2-associated death promoter) the
accessibility of serine 155 of BAD for other kinases increased [30].
GlobPlotH analysis revealed unstructured regions in the IRS-2
protein, which could potentially be restructured/reshaped upon 14-
3-3 binding. Since IRS-2 functions as a multi-adapter protein,
thereby linking the insulin receptor and other receptor tyrosine
kinases with intracellular effector molecules, 14-3-3 proteins could
modulate the interactions with binding partners by binding to IRS-2
uponphosphorylationofserine573andapossibleyet tobediscovered
second binding site.
In summary, we demonstrate the identification of 24 phosphor-
ylation sites including novel sites on IRS-2 and mapped the IGF-
1/insulin-dependent 14-3-3 binding region. Serine 573 as novel
phosphorylation site was shown to be part of IGF-1/insulin-
dependent interaction between 14-3-3 and IRS-2 and its
phosphorylation may have an inhibitory role in IGF-1/insulin
signaling. The evidence of the interaction between 14-3-3 proteins
and the signal transducer IRS-2 in vivo opens several novel
perspectives in the (patho)physiological regulation of the biological
function of IRS-2 including its role in metabolic disorders such as
insulin resistance and type 2 diabetes.
Table 1. With mass spectrometry identified residues with
surrounding amino acids that correspond to a 14-3-3 binding
motif.
residue peptide
303 RSKRSKpSQSSGSS
401 PLSRSHpTLSAGCG
517 SSHRSNpTPESIAE
556 RPYRRVpSGDGAQD
573 LRKRTYpSLTTPAR
Shown are the identified residues indicated in bold with pS or pT and the
surrounding 6 amino acids before and after the phosphorylated residue.
doi:10.1371/journal.pone.0043296.t001
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Materials and Methods
Ethics Statement
The animal experiments were conducted in accordance with the
national guidelines of laboratory animal care and were approved
by the local governmental commission for animal research (M6/
08, Regierungspraesidium Tuebingen, Baden-Wuerttemberg,
Germany).
Materials
Flp-In HEK293 cells were from Invitrogen (Karlsruhe, Ger-
many), Fao and HEK293 cells from The European Collection of
Cell Cultures (Salisbury, UK). Insulin, IGF-1 and phosphatase
inhibitors (sodium fluoride, sodium pyrophosphate, sodium
orthovanadate and b-glycerophosphate) were obtained from
Sigma (Munich, Germany), wortmannin and Akt/PKB inhibitor
(Akti-1/2) from Calbiochem (Schwalbach, Germany). IRS-2
Figure 4. Ser-573 of IRS-2 is an IGF-1-dependent 14-3-3 binding site. A. HEK293 cells were transiently transfected with GFP-IRS2, GFP-IRS2-
S303A, GFP-IRS2-T401A, GFP-IRS-2-T517A, GFP-IRS2-S556A or GFP-IRS2-S573A and stimulated with 50 ng/ml IGF-1 for 30 min or after preincubation
with 1 mM PI-103 30 min prior IGF-1 stimulation. 250 mg of total protein were used for GFP pulldown and overlay assay was performed. Stripping
followed reprobing of the membrane with GFP antibody as loading and expression control. B. Transiently with GFP-IRS2 or GFP-IRS2-S573A
transfected HEK293 cells were stimulated with 50 ng/ml IGF-1 alone for 30 min or after preincubation with 100 nM wortmannin for 30 min. 100 mg
of total protein was used for GFP pulldown, separated on 5–15% SDS gels and overlay assay was performed. Corresponding GFP reblot as expression
and loading control is shown C. Flp-In HEK293 cells stably expressing GFP-IRS2 or GFP-IRS2-S573A were stimulated as in A and cell lysis was followed
by pull down of 400 mg total protein. Samples were divided into two equal volumes and separated on SDS-PAGE. One membrane was used for
overlay assay, the other one was directly incubated with GFP antibody. D. Interaction of 14-3-3 with IRS-2 from B was quantified scanning
densitometry of Western blots (mean 6 SEM; n = 3; *p,0.05 IRS-2 wild type IGF-1 vs. IRS-2 wild type wortmannin/IGF-1).
doi:10.1371/journal.pone.0043296.g004
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polyclonal protein antibody (06–506) was from Millipore (Schwal-
bach, Germany), Akt/PKB protein antibody (610861) from BD
Transduction Laboratories (Erembodegem, Belgium), GFP (green
fluorescent protein) polyclonal protein antibody (8334), 14-3-3 (C-
17) (732) and 14-3-3 K-19 (629) from Santa Cruz (Santa Cruz,
USA) and phosphospecific Thr-308-Akt/PKB (9275) as well as
Ser-473-Akt/PKB (9271) from Cell Signaling (Boston, USA).
Recombinant human 14-3-3f-HRP was from R&D Systems
(Minneapolis, USA). Trypsin gold, mass spectrometry grade was
from Promega (Madison, USA), 4–12% Bis-Tris mini gels and
Colloidal Blue Staining Kit were from Invitrogen (Karlsruhe,
Germany). Protease Inhibitor Cocktail Tablets were from Roche
and the Protein Assay was from BioRad (Munich, Germany).
Protein A Sepharose, Sepharose 4B and GST (glutathione S-
transferase) antibody (27-4577-01) were from GE Healthcare
Europe (Munich, Germany). GFP-TrapH was obtained from
Chromotek (Martinsried, Germany).
Cell Culture and Transfection
All cell lines were kept in a 5% CO2-atmosphere with 95%
humidity at 37uC. HEK293 and Flp-In HEK293 cells were
cultivated in DMEM with 4.5 g/l glucose, supplemented with
10% FBS, 1% glutamine, 100 U/ml penicillin and 100 U/ml
streptomycin. Fao cells were cultivated inRPMI1640 supplemented
with 10% FBS, 1% glutamine, 100 U/ml penicillin and 100 U/ml
streptomycin. Flp-In HEK293 and HEK293 cells were transfected
either transiently with polyethylenimine or stably with the Calcium
Phosphate method [52] and positive clones were selected with
Hygromycin B. Fao cells were used at confluency. Stimulation of
cells was carried out after starvation for serum with various
substances as described in detail in the results part/legends.
Cell Lysis, Immunoprecipitation and Western Blotting
Cells were lysed with lysis buffer consisting of 50 mM HEPES,
150 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 10% glycerol, 1%
Figure 5. Sequence alignments and characterization of a polyclonal antibody raised in sheep against position Ser-573 on IRS-2. A.
Sequence alignment of the amino acids adjacent to the 14-3-3 binding site Ser-573 of IRS-2 in different species. B. Shown is the amino acid sequence
surrounding Ser-573 in mouse IRS-2 and the sequence surrounding the homologue position Ser-522 in mouse/rat IRS-1. C. Flp-In HEK293 cells stably
expressing GFP-IRS2 or GFP-IRS2-S573A were starved for serum followed by stimulation for 30 min with 50 ng/ml IGF-1 or after preincubation with
100 nM wortmannin for 30 min. 200 mg of lysate was separated on a 7.5% SDS gel, membrane was probed with p-Ser-573 antibody. Expression was
checked by stripping the membrane and reprobing with GFP antibody. D. HEK293 cells were co-transfected transiently with mouse IRS-2/IR (insulin
receptor), human IRS-2/IR and rat IRS-1/IR and stimulated with 10 nM insulin for 30 min. Membranes were incubated with p-Ser-573 antibody and
reprobed with the corresponding protein antibodies. IR expression was also checked.
doi:10.1371/journal.pone.0043296.g005
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Triton-X-100, set to pH 7.5, containing phosphatase inhibitors
(10 mM NaF, 5 mM sodium pyrophosphate, 10 mM sodium
orthovanadate, 10 mM b-glycerophosphate). Lysates were cleared
by centrifugation for 5 min at 4uC with 16000 g. IRS-2 was
immunoprecipitated with 2 mg IRS-2 antibody coupled to Protein
A Sepharose for 4 hours at 4uC. 14-3-3 was immunoprecipitated
by mixing lysates with 2 mg 14-3-3 antibody for 3 hours and
adding 30 ml Protein G Sepharose for another hour. The
Sepharose pellet was washed two times with lysis buffer and
resuspended in 5x Laemmli (1 M Tris-HCl, pH 6.8, 50% glycerin,
10% SDS, 5.5% b-mercaptoethanol). Proteins were separated on
either 7.5% or 5–15% SDS gels followed by transfer onto
nitrocellulose membranes using semi-dry Western blot. Western
blotting and enhanced chemiluminescence was described previ-
ously [53].
Plasmid Constructs
All plasmids to express GFP tagged proteins were generated at
the University of Dundee (UK). All PCR and mutagenesis
reactions were carried out using KOD Hot Start DNA polymerase
(Novagen). The coding region for mouse IRS-2
(NM_001081212.1) was amplified from a pRK5 IRS-2 vector
(kindly provided by M.F. White, Boston, MA, USA) using primers
59-gaggatccatggctagcgcgcccctgcctg-39 and 59-ctgcggccgctcgagt-
cactctttcacgactgtggcttccttc-39, cloned into vector pSC-B (Strata-
gene) and sequenced. IRS-2 was sub-cloned from this plasmid into
pcDNA5/FRT/TO-GFP as a BamH1/Not1 insert to give vector
pcDNA5/FRT/TO-GFP-IRS2 in which IRS-2 is tagged with
GFP at the N-terminus. For truncated IRS-2 versions containing
the IRS-2 sequence from amino acid 1–300 and 1–600 a stop
codon was created after position 300 (sense: 59-gagttccggcctcgct-
gaaagagtcagtcgtcc-39; antisense: 59-ggacgactgactctttcagcgaggccg-
gaactc-39) or 600 (sense: 59-ctcatgagggccacctgatctggtagttcaggtc-39;
antisense: 59-gacctgaactaccagatcaggtggccctcatgag-39) respectively.
For the constructs 301–1321 and 601–1321 a BamHI restriction
site was created prior positions 301 and 601 and the obtained
inserts were ligated into pcDNA5/FRT/TO-GFP. Construct
301–600 was generated by creating a stop codon after position
600 and pcDNA5/FRT/TO-GFP-IRS2-301–1321 served as
template. pcDNA5/FRT/TO-GFP-IRS2 served as template for
the point mutation of serine 573 to alanine (sense: 59-gaggaa-
gaggacttatgccctaaccacgcctg-39; antisense: 59-caggcgtggttagggca-
taagtcctcttcctc-39) and for the point mutation of serine 556 to
alanine (sense: 59-ccttaccgtagggtcgcaggggatggggccc-39; antisense:
59-gggccccatcccctgcgaccctacggtaagg-39). pcDNA5/FRT/TO-
GFP-IRS2-S556A served as template for the generation of double
mutant S556A/S573A (sense: 59- gaagaggacttatgccctaaccacgcctg-
39; antisense: 59-caggcgtggttagggcataagtcctcttc-39). DNA sequenc-
ing was performed by The Sequencing Service, College of Life
Sciences, University of Dundee (www.dnaseq.co.uk). The plasmid
construct for human IRS-2 was from Calum Sutherland
(University of Dundee).
GFP Pull Down and Far Western Blot
All centrifugation steps were carried out at 4uC for 2000 g for
1 min. Precleared lysates were transferred into fresh tubes
containing a 50% slurry of a mixture of Protein A Sepharose
and GFP-TrapH and samples were mixed for 2 hours at 4uC.
After washing twice with high salt buffer (50 mM Tris, pH 7.5,
150 mM NaCl) and twice with no salt buffer (50 mM Tris,
pH 7.5, 1 mM EGTA, 0.1% mercaptoethanol), the pellet was
resuspended in 5x Laemmli buffer. Proteins were separated on
5–15% gradient gels and transferred onto nitrocellulose mem-
branes. For Far Western blot membranes were blocked in 5%
milk powder in TBS-T (25 mM Tris, pH 7.4, 0.15 M NaCl,
0.1% Tween 20) for 1 hour at room temperature. Incubation of
the membrane overnight at 4uC with recombinant human 14-3-
3f-HRP was followed by washing with TBS-T and visualization
using ECL. Incubation of membranes with 14-3-3f-HRP will be
referred to as overlay assay.
Figure 6. Inhibition of Akt/PKB reduces IGF-1-induced phos-
phorylation of serine 573 and 14-3-3 binding. A. Flp-In
HEK293 cells stably expressing GFP-IRS2 were starved for serum and
incubated for 30 min with 50 ng/ml IGF-1 or 1 mM Akti-1/2 alone, or
Akti-1/2 preincubation followed IGF-1 stimulation. 100 mg of total
protein was separated on 7.5% SDS gels and membranes were probed
with p-Ser-573 and p-Thr-308 of Akt/PKB. Membranes were stripped
and reprobed with respective antibodies for detection of protein levels.
B. Effect of Akt/PKB inhibition on serine 573 phosphorylation was
assessed by scanning densitometry of blots and normalization for
protein (mean 6 SEM; n= 3; *p,0.05 IGF-1 vs. Akti/IGF-1). C. GFP
pulldown from Flp-In HEK293 cells stably expressing GFP-IRS2, stimu-
lated as in A. 200 mg protein was pulled down and overlay assay
followed reprobing with IRS-2 antibody. 100 mg of total protein was
separated on 7.5% SDS gel and membrane was checked for p-Thr-308
phosphorylation and reprobed with Akt/PKB protein antibody.
doi:10.1371/journal.pone.0043296.g006
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Expression of GST Fusion Proteins and GST Pulldown
GST-14-3-3b and GST-14-3-3e constructs were a kind gift from
Angelika Hausser (University of Stuttgart). The GST-14-3-3
plasmids were propagated in E. coli and protein expression was
induced by 1 mM IPTG (isopropyl b-D-1-thiogalactopyranoside)
for 5 hours. Bacterial cells were harvested at 4uC by centrifugation
with 4500 g for 15 min and disrupted by applying 40 strokes with
a probe-type sonicator. After adding Triton-X-100 to a final
concentration of 1% the suspension was centrifuged at 4500 g for
20 min at 4uC. GST-14-3-3 proteins were coupled to 50% slurry
of glutathione Sepharose 4B. The amount of GST-14-3-3 was
determined by SDS-PAGE followed by Coomassie staining.
Lysates were incubated with 2 mg GST-14-3-3 for 2 hours in lysis
buffer at 4uC. Beads were washed three times with lysis buffer,
resuspended in 5x Laemmli and denaturated at 95uC for 5 min.
Polyclonal Antibody Against Phosphorylated Serine 573
The peptide CLRKRTYS*LTTPAR (residues 567–579, *indi-
cates phosphorylated serine) was used to generate a phosphospe-
cific antibody against phosphorylated residue 573 of mouse IRS-2.
The phosphopeptide was conjugated to KLH (keyhole limpet
haemocyanin) and BSA using MBS (m-maleimidobenzoic acid N-
hydroxysuccinimide ester) according to the method of Harlow and
Lane [54]. Five aliquots containing 0.5 mg of each peptide
conjugate were sent to the Scottish Blood Transfusion Service,
Penicuik, Scotland. Injection into sheep at monthly intervals was
followed by collecting serum at monthly intervals and purification
by affinity chromatography against the appropriate phosphorylat-
ed peptide.
Sample Preparation for Mass Spectrometry
HEK293 cells were seeded onto 10 cm diameter plates,
transfected with 10 mg DNA of GFP or GFP-IRS2 and 30 mg
polyethylenimine in 25 mM HEPES/plate, starved for serum and
stimulated with 50 ng/ml IGF-1 for 30 min and after preincuba-
tion with 1 mM PI-103. Cell lysis was done in lysis buffer (50 mM
Tris-HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 1% Triton-X-
100, 1 mM sodium orthovanadate, 50 mM sodium fluoride,
5 mM sodium pyrophosphate) containing a Protease Inhibitor
Cocktail tablet. Protein determination was followed by immuno-
precipitation of GFP proteins from 10 mg of total protein using
15 ml GFP TrapH and separation on precast 4–12% Bis-Tris gels.
Staining overnight using the Colloidal Blue Staining Kit followed
cutting of IRS-2 bands and transfer into 1.5 ml reaction tubes. Gel
pieces were washed sequentially with ultrapure H2O, 50%
methanol/H2O, 0.1 M NH4HCO3 and methanol/50 mM
NH4HCO3. Proteins were incubated with 10 mM DTT/0.1 M
NH4HCO3 at 65uC for 45 min, followed by alkylation with
50 mM iodacetamide/0.1 M NH4CO3 in the dark for 20 min at
room temperature. Washing of gel pieces using 50 mM
NH4HCO3 and 50 mM NH4HCO3/50% methanol was followed
by shrinking the pieces with methanol for 15 min and drying in a
Speed-Vac. Gel pieces were soaked in 20 mM triethylammonium
bicarbonate containing 5 mg/ml trypsin and shaken at 30uC
overnight. Methanol was added and samples shaken for 15 min
before the supernatant was removed and samples were dried in a
Speed-Vac. Residual peptides were extracted from the gel pieces
with 50% methanol/2.5% formic acid and the supernatant was
combined with the first dried extract and dried completely.
Mass Spectrometry
IRS-2 tryptic digests were analysed by LC-MS (liquid chroma-
tography mass spectrometry) on a LTQ-orbitrap classic mass
spectrometer system (Thermo Fisher Scientific, Schwerte, Ger-
many) coupled to a Proxeon Easy-LC HPLC system. The peptide
mixtures were loaded onto a nanoseparations C18 guard column
(0.1620 mm) equilibrated in 0.1% formic acid/water at 5 ml/min
and then separated on a 0.0756150 mm PepMap C18 column,
equilibrated in 0.1% formic acid/water (LC Packings, Amsterdam,
Netherlands). Peptides were eluted with a 100 min discontinuous
gradient of acetonitrile/0.1% formic acid at a flow rate of 300 nl/
min. The column outlet was connected to a Thermo Fisher
Nanospray 1 source fitted with a New Objective FS360 20-10
uncoated emitter and a voltage of 1.3 kV was applied to the
Figure 7. Insulin induces binding of 14-3-3 to endogenous IRS-2 and phosphorylates Ser-573 on IRS-2. A. Fao cells were starved for
serum overnight and incubated for 30 min with either 10 nM insulin or 50 ng/ml IGF-1. 250 mg protein was immunoprecipitated with IRS-2 antibody
and separated on a 5–15% gradient gel. Overlay assay followed stripping and reprobing with IRS-2 antibody as loading control. Successful stimulation
is shown as phosphorylation of p-Thr-308 and corresponding Akt/PKB reblot. B. Fao cells were starved for serum overnight and stimulated with
10 nM insulin for the indicated time points. 100 mg of protein was separated on a 7.5% gel and membranes were probed with specific antibodies
against p-Ser-573 of IRS-2 and p-Thr-308 of Akt/PKB. For loading control membranes were stripped and reprobed with protein antibody.
doi:10.1371/journal.pone.0043296.g007
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emitter. The orbitrap was set to analyse the survey scans (m/z
350–2000) at 60.000 resolution and top 5 ions in each duty cycle
(minimum ion intensity of 50000 cps), were selected for MSMS in
the LTQ linear ion trap with multistage activation. Ions were
excluded for 30 s after 2 occurrences. The raw files were converted
into mascot generic files using Raw2msm (a gift from M. Mann,
Martinsried, Germany). The MSMS spectra (mgf file) were
searched against SwissProt database using the Mascot search
Figure 8. Ser-573 influences phosphorylation of Akt/PKB. A. HEK293 cells transiently expressing GFP-IRS2 or GFP-IRS2-S573A were stimulated
with 50 ng/ml IGF-1 for the indicated time points. 40 mg of total protein was separated on 7.5% SDS gels and membranes were incubated with GFP
antibody to ensure equal expression levels and with p-Thr-308 and p-Ser-473 antibody respectively. Corresponding Akt/PKB reblots are shown. B.
Densitometric analyses of Akt/PKB phosphorylation. Black diamonds represent IRS-2 wild type, white squares IRS2-S573A mutant. Phosphorylation
was normalized against total protein and IRS-2 wild type stimulated with IGF-1 for 5 min was set as 1 (mean 6 SEM; n = 3; *p,0.05 IRS-2 120 min vs.
S573A 120 min; IRS-2 240 min vs. S573A 240 min).
doi:10.1371/journal.pone.0043296.g008
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engine (Matrix Science) run on an in-house server using the
following criteria: peptide tolerance = 10 ppm; trypsin as the
enzyme; carboxyamidomethylation of cysteine as a fixed modifi-
cation with oxidation of methionine and phosphorylation of serine,
threonine and tyrosine as a variable modification. Any MSMS
spectra that could be assigned to a phosphopeptide was inspected
manually using QualBrowser software. IRS-2 tryptic digests were
also analysed by LC-MS with precursor of 79 scanning on a 4000
Q-Trap system (Applied Biosystems, Carlsbad, US) as described
previously [55]. Extracted ion chromatograms for all detected
phosphopeptides were generated using Analyst 1.4.1 software.
Animal Studies
Male C57Bl/6 mice were from Charles River (Sulzfeld,
Germany), maintained at a 12 hours dark/light cycle under
standard chow. Liver was homogenized at 4uC in lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton-X-100,
containing Protease Inhibitor Complete Tablet and phosphatase
inhibitors). Homogenates were cleared after 30 min of solubilization
on ice by 3 centrifugation steps at 16 000 g for 10 min at 4uC. All
procedures were approved by the local Animal Care and Use
committee.
Statistical Analyses
Data are presented as means 6 SEM. Unpaired student’s t-test
was employed and a result was considered significant if p,0.05.
Supporting Information
Table S1 Phosphopeptides detected by mass spectrom-
etry that are common to IRS-2 isolated from serum
starved and IGF1 treated cells. GFP-IRS2 was expressed
transiently in HEK293 cells and cells were either left unstimulated
or stimulated with IGF-1 for 30 minutes. Using GFP-TrapH IRS-2
was purified from total cell lysate and after SDS-PAGE and
Coomassie staining, the bands corresponding to IRS-2 were cut
and peptides were digested using trypsin (M=molecular mass of
the peptide in Dalton, m/z=mass to charge). A mass accuracy of
10 ppm was used in database searches and phosphosites were
identified by MS/MS analysis and manual inspection of the
spectra. The sequence coverage was 92%. The phosphorylated
residues are indicated with pS or pT.
(DOC)
Table S2 Phosphopeptides detected by mass spectrom-
etry that are unique to IRS-2 isolated from IGF-1-treated
cells. Samples were prepared as in Table S1. The phosphorylated
residues are indicated with pS or pT.
(DOC)
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